So glad to support City of Hope Sumanta Pal for the nominating committee in the ASCO elections!
Monty’s bedside manner and patient care is what I still try to emulate today. He is an exceptionally generous and thoughtful leader! I hope you’ll support him at the polls on 11/2!

chadi nabhan MD, MBA, FACP Rana McKay Toni Choueiri, MD Sumanta Pal Shilpa Gupta You nailed it chadi nabhan MD, MBA, FACP Here is the GU Cancer Research Program @HuntsmanCancer team Huntsman Cancer Institute working hard on the ASCO GU symposium abstracts

💫Interim Analysis PADRES by Kevin Hakimi #KCRS22
KidneyCAN OncoAlert
Rana McKay Brian Rini, MD

Approximately every 3 minutes someone in the United States is diagnosed with a blood cancer. This weekend the Beacon of Hope is red in honor of blood cancer patients, their loved ones, and our clinical and research staff.

Neeraj Agarwal Vivek Subbiah, MD Binaytara Foundation Binay Shah, MD, MHA Petros Grivas H. Jack West, MD Theresa Werner MD Sid Yadav MD, FACP Beverly Chigarira Sumanta Pal Wafik S. El-Deiry, MD, PhD, FACP, FRSM gilberto lopes chadi nabhan MD, MBA, FACP Emil Lou, MD, PhD, FACP Mike Thompson, MD, PhD, FASCO Aakash Desai, MD, MPH Jacob J. Adashek, DO Shilpa Gupta Toni Choueiri, MD Sewanti Limaye 🇮🇳🇺🇸 GU Cancer Research Program @HuntsmanCancer Huntsman Cancer Institute Umang Swami Roberto Nussenzveig Nishita Tripathi Neli Ulrich, PhD Nicolas Sayegh Li Haoran, MD, PhD Dr. Kamal Kant Sahu Nicolas Sayegh GU Cancer Research Program @HuntsmanCancer gives an excellent presentation on the genomic characteristics of dn-hv-mCSPC compared to those without dn-hv-mCSPC Huntsman Cancer Institute IMG Oncologists Binaytara Foundation

Vivek Subbiah, MD Binaytara Foundation Binay Shah, MD, MHA Petros Grivas H. Jack West, MD Theresa Werner MD Sid Yadav MD, FACP Beverly Chigarira Sumanta Pal Wafik S. El-Deiry, MD, PhD, FACP, FRSM gilberto lopes chadi nabhan MD, MBA, FACP Emil Lou, MD, PhD, FACP Mike Thompson, MD, PhD, FASCO Aakash Desai, MD, MPH Jacob J. Adashek, DO Shilpa Gupta Toni Choueiri, MD Sewanti Limaye 🇮🇳🇺🇸 Beverly Chigarira GU Cancer Research Program @HuntsmanCancer gives a thoughtful talk on challenges with somatic tumor genomic testing👉Challenges and solutions. Binaytara Foundation #precisiononcology summit Huntsman Cancer Institute

✅So excited to join Neeraj Agarwal & amazing colleagues for the #PrecisionOncology Binaytara Foundation summit in Salt Lake City, Utah today: Oct 7
👉🏼Program: bit.ly/3e8aNIu Binaytara Foundation Binay Shah, MD, MHA Petros Grivas H. Jack West, MD Theresa Werner MD Sid Yadav MD, FACP Beverly Chigarira Sumanta Pal

Vivek Subbiah, MD Binaytara Foundation Binay Shah, MD, MHA Petros Grivas H. Jack West, MD Theresa Werner MD Sid Yadav MD, FACP Beverly Chigarira Sumanta Pal Wafik S. El-Deiry, MD, PhD, FACP, FRSM gilberto lopes chadi nabhan MD, MBA, FACP Emil Lou, MD, PhD, FACP Mike Thompson, MD, PhD, FASCO Aakash Desai, MD, MPH Jacob J. Adashek, DO Shilpa Gupta Toni Choueiri, MD Sewanti Limaye 🇮🇳🇺🇸 Sid Yadav MD, FACP Mayo Clinic presents his work on nuances of germline testing👉 affect of race and polygenic scores, challenges, changing classification of VUS to pathogenic variants and vice versa. Binaytara Foundation Binay Shah, MD, MHA #PrecisionOncology summit

Neeraj Agarwal Vivek Subbiah, MD Binaytara Foundation Binay Shah, MD, MHA Petros Grivas H. Jack West, MD Theresa Werner MD Sid Yadav MD, FACP Beverly Chigarira Sumanta Pal Wafik S. El-Deiry, MD, PhD, FACP, FRSM gilberto lopes chadi nabhan MD, MBA, FACP Emil Lou, MD, PhD, FACP Mike Thompson, MD, PhD, FASCO Aakash Desai, MD, MPH Jacob J. Adashek, DO Shilpa Gupta Toni Choueiri, MD Sewanti Limaye 🇮🇳🇺🇸 Mayo Clinic GU Cancer Research Program @HuntsmanCancer Umang Swami Nicolas Sayegh Vinay Mathew Thomas Neli Ulrich, PhD Roberto Nussenzveig Dr Manish Kohli presented clinical utility of circulating tumor DNA in cancer treatment: pre-analytic, analytic & post - analytic issues including laboratory platforms, insurance coverage, etc at #PrecisionOncology summit in #SLC . Binaytara Foundation Binay Shah, MD, MHA

Excellent presentations Vinay Mathew Thomas Dr. Kamal Kant Sahu Sid Yadav MD, FACP Paolo Tarantino Vivek Subbiah, MD

#Precisiononcology summit in #SLC : Dr Vivek Subbiah, MD presented beyond sequencing - methods in identifying tumor biomarkers for targeted therapies. 👇Program: bit.ly/3e8aNIu
Binaytara Foundation Binay Shah, MD, MHA Neeraj Agarwal

The prostate cancer abstracts continue at the Precision Oncology Summit in SLC with Vinay Mathew Thomas Dr. Kamal Kant Sahu Nicolas Sayegh with fantastic oral presentations! Neeraj Agarwal Umang Swami GU Cancer Research Program @HuntsmanCancer Binaytara Foundation Utah Hematology/Oncology Fellows

Precision Oncology Summit in Salt Lake City is underway with abstract session! HCIs very own Li Haoran, MD, PhD starting us off with access to care for GU cancers for urban vs rural patients Binaytara Foundation Neeraj Agarwal Dr. Kamal Kant Sahu Nishita Tripathi Nicolas Sayegh Umang Swami GU Cancer Research Program @HuntsmanCancer HCI Community Outreach and Engagement

Sumanta Pal Luis A. Meza City of Hope Nishita Tripathi Huntsman Cancer Institute Tejas Jammihal Rana McKay Stephanie Berg Toni Choueiri, MD @KevinZarrabi Bryan Lewis Petros Grivas KidneyCAN Zeynep Zengin Nazli Dizman Katy Beckermann Neli Ulrich, PhD Vivek Subbiah, MD Hans Hammers #KCRS22 KidneyCAN Brilliant moderation by Rana McKay Stephanie Berg Kudos to program committee for dedicated sessions on young investigators. Wonderful talks by Nishita Tripathi Luis A. Meza GU Cancer Research Program @HuntsmanCancer Genitourinary Cancer Research Team @CityofHope

Join us in #PrecisionOncology summit in Salt Lake City, this weekend: Oct 7 Friday afternoon-Oct 8 Saturday. World class faculty, Venue: downtown👇Program: bit.ly/3e8aNIu Binaytara Foundation Binay Shah, MD, MHA Vivek Subbiah, MD H. Jack West, MD Theresa Werner MD Sid Yadav MD, FACP Beverly Chigarira

JUST IN: TRITON3 Phase 3 Trial Of Achieves Primary Endpoint In Men With Metastatic Castration-Resistant Prostate Cancer With BRCA/ATM Mutations

ir.clovisoncology.com/investors-and-…

Dana-Farber Lank Center for Genitourinary Oncology OncoAlert Clovis Oncology

🥁Check out 👉 Amazing review on the clinical and molecular rationale for the use of Erdafitinib in the treatment of advanced urothelial carcinoma #bladdercancer by Nicolas Sayegh Nishita Tripathi Neeraj Agarwal Umang Swami 👉 bit.ly/3e6EN7J UroToday.com OncoAlert @Bcan Dove Medical Press

We're getting close to #IDWeek2022 ! Our Editor-in-Chief, Andrés Henao, MD, & Managing Editor, Hemali Bedi, can't wait to see you there in person for the first time in three years!

Got a question? We want to hear from you! Get in touch to arrange a meeting: [email protected]📧

Talapro-2 positive on the heels of PROPEL in mCRPC all comers for parpi plus NHA . Time to look beyond the obvious HRR targets for #prostatecancer ! Joaquin Mateo Alan H Bryce Elena Castro Neeraj Agarwal Gil Morgan

Breaking news: Phase 3 randomized TALAPRO-2 trial of Enza + Talazoparib vs. Enza meets primary endpoint in the 1st line mCRPC #ProstateCancer in both HRR+ and HRR- patients (study design👇).Press release 👉 bit.ly/3SSjJAp OncoAlert UroToday.com GU Cancer Research Program @HuntsmanCancer PCF Science